Goldman Sachs Group Inc. increased its stake in Calumet, Inc. (NASDAQ:CLMT - Free Report) by 33.5% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 465,269 shares of the oil and gas company's stock after buying an additional 116,777 shares during the period. Goldman Sachs Group Inc. owned 0.54% of Calumet worth $5,900,000 at the end of the most recent reporting period.
Analyst Ratings Changes
Separately, UBS Group raised their target price on shares of Calumet from $12.00 to $13.25 and gave the company a "neutral" rating in a research note on Tuesday, August 12th. Four investment analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. According to MarketBeat.com, Calumet has an average rating of "Moderate Buy" and a consensus price target of $18.71.
Read Our Latest Analysis on CLMT
Calumet Price Performance
Shares of Calumet stock traded down $0.07 during trading hours on Friday, reaching $18.51. The company's stock had a trading volume of 1,733,858 shares, compared to its average volume of 872,394. Calumet, Inc. has a one year low of $7.68 and a one year high of $25.29. The firm has a 50 day moving average price of $16.16 and a 200-day moving average price of $14.06. The stock has a market cap of $1.61 billion, a P/E ratio of -3.55 and a beta of 0.97.
Calumet (NASDAQ:CLMT - Get Free Report) last released its quarterly earnings results on Friday, August 8th. The oil and gas company reported ($1.70) EPS for the quarter, missing analysts' consensus estimates of ($0.44) by ($1.26). The company had revenue of $1.03 billion for the quarter, compared to analysts' expectations of $982.88 million. During the same period in the previous year, the company posted ($0.48) earnings per share. The company's revenue for the quarter was down 9.4% compared to the same quarter last year. As a group, sell-side analysts forecast that Calumet, Inc. will post -3.02 EPS for the current fiscal year.
Calumet Company Profile
(
Free Report)
Calumet, Inc engages in the manufacturing, formulating, and marketing of a diversified slate of specialty branded products and renewable fuels to customers across a broad range of consumer-facing and industrial markets. It operates through the following segments: Specialty Products & Solutions, Performance Brands, Montana/Renewables, and Corporate.
Read More

Before you consider Calumet, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Calumet wasn't on the list.
While Calumet currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.